Top

Published in:

01-05-2016 | Original Article

Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway

Authors: Qian Peng, Yan Deng, Xiling Yang, Xiangyou Leng, Yuan Yang, Hanmin Liu

Published in: European Journal of Pediatrics | Issue 5/2016

Abstract

Kawasaki disease (KD) is a systemic vasculitis childhood disease frequently complicating coronary artery lesions (CALs). Recently, the gene encoding a disintegrin and metalloprotease 17 (ADAM17) was found to modify vascular pathology in humans by differentially regulating the transforming growth factor-β (TGF-β) signaling pathway, which affects KD/CAL susceptibility. To explore the potential role of ADAM17 in KD occurrence and outcomes, we investigated the association of 28 single nucleotide polymorphisms (SNPs) in ADAM17 and three pathway genes of TGF-β signaling with KD phenotypes in a Han Chinese population, including 392 KD patients and 421 non-KD controls. Three ADAM17 SNPs showed an association with KD risk, which was further confirmed by haplotype analysis. The effect of ADAM17 on KD was also shown by multi-variable logistic regression analysis. In two-locus model analyses with SNPs in ADAM17 and TGF-β signaling pathway genes, stronger compound effects on the risk of KD and secondary CAL formation were observed relative to comparable single SNPs.

Conclusion: Our results suggest that ADAM17 contributes to the KD risk and is involved in secondary CAL formation via the TGF-β/SMAD3 signaling pathway. This further enriches our understanding of the importance of the signaling pathway in KD occurrence and outcomes.

What is Known:

• The transforming growth factor (TGF)-β/SMAD3 signaling pathway greatly influences susceptibility to Kawasaki disease (KD) and secondary coronary artery lesions (CALs) and/or the treatment response of intravenous immunoglobulin.

• A disintegrin and metalloprotease 17 (ADAM17) effectively reduces TGF-β signaling by cleaving TGF-β receptor type-1, while ADAM17 genetic variants modify human vascular pathology by differentially regulating this signaling although it is unknown whether ADAM17 contributes to KD phenotypes.

What is New:

• ADAM17 genetic variants were shown to be associated with KD risk, even when excluding the influence of TGF-β signaling pathway genes, suggesting that ADAM17 is an important KD susceptibility-related genetic locus.

• The more significant compound effects of two-locus models, combining single nucleotide polymorphisms (SNPs) in ADAM17 and other TGF-β signaling pathway genes including TGFB2 and SMAD3, on KD phenotypes relative to single SNPs suggest that ADAM17 is also involved in secondary CAL formation and confers the risk of KD/CALs via the TGF-β/SMAD3 signaling pathway.

Available only for authorised users

Borzutzky A, Hoyos-Bachiloglu R, Cerda J, Talesnik E (2012) Rising hospitalization rates of Kawasaki disease in Chile between 2001 and 2007. Rheumatol Int 32:2491–2495. doi:10.1007/s00296-011-2050-4 CrossRefPubMed

Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116:2127–2138CrossRefPubMed

Chang CJ, Kuo HC, Chang JS, Lee JK, Tsai FJ, Khor CC, Chang LC, Chen SP, Ko TM, Liu YM, Chen YJ, Hong YM, Jang GY, Hibberd ML, Kuijpers T, Burgner D, Levin M, Burns JC, Davila S, International Kawasaki Disease Genetics Consortium, Korean Kawasaki Disease Genetics Consortium, Taiwan Kawasaki Disease Genetics Consortium, Chen YT, Chen CH, Wu JY, Lee YC (2013) Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One 8, e72037. doi:10.1371/journal.pone.0072037 CrossRefPubMedPubMedCentral

Choi YM, Shim KS, Yoon KL, Han MY, Cha SH, Kim SK, Jung JH (2012) Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease. Korean J Pediatr 55:18–23. doi:10.3345/kjp.2012.55.1.18 CrossRefPubMedPubMedCentral

Du ZD, Zhao D, Du J, Zhang YL, Lin Y, Liu C, Zhang T, Beijing Kawasaki Research Group (2007) Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J 26:449–451CrossRef

Duan J, Lou J, Zhang Q, Ke J, Qi Y, Shen N, Zhu B, Zhong R, Wang Z, Liu L, Wu J, Wang W, Gong F, Miao X (2014) A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis. PLoS One 9, e103329. doi:10.1371/journal.pone.0103329 CrossRefPubMedPubMedCentral

Harnden A, Alves B, Sheikh A (2002) Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 324:1424–1425CrossRefPubMedPubMedCentral

Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 29:483–488. doi:10.1097/INF.0b013e3181cf8705 PubMed

Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385CrossRefPubMed

10.

Kawasaki K, Freimuth J, Meyer DS, Lee MM, Tochimoto-Okamoto A, Benzinou M, Clermont FF, Wu G, Roy R, Letteboer TG, Ploos van Amstel JK, Giraud S, Dupuis-Girod S, Lesca G, Westermann CJ, Coffey RJ Jr, Akhurst RJ (2014) Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans. Proc Natl Acad Sci U S A 111:7723–7728. doi:10.1073/pnas.1318761111 CrossRefPubMedPubMedCentral

11.

Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222PubMed

12.

Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, Yeung RS, Tan DE, Sim KS, Wang JJ, Wong TY, Pang J, Mitchell P, Cimaz R, Dahdah N, Cheung YF, Huang GY, Yang W, Park IS, Lee JK, Wu JY, Levin M, Burns JC, Burgner D, Kuijpers TW, Hibberd ML, Hong Kong–Shanghai Kawasaki Disease Genetics Consortium, Korean Kawasaki Disease Genetics Consortium, Taiwan Kawasaki Disease Genetics Consortium, International Kawasaki Disease Genetics Consortium, US Kawasaki Disease Genetics Consortium, Blue Mountains Eye Study (2011) Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 43:1241–1246. doi:10.1038/ng.981 CrossRefPubMed

13.

Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, Kim DS, Park S (2014) Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 33:24–27. doi:10.1097/INF.0000000000000010 CrossRefPubMed

14.

Kuo HC, Onouchi Y, Hsu YW, Chen WC, Huang JD, Huang YH, Yang YL, Chao MC, Yu HR, Juan YS, Kuo CM, Yang KD, Huang JS, Chang WC (2011) Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population. J Hum Genet 56:840–845. doi:10.1038/jhg.2011.113 CrossRefPubMed

15.

Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, Liang CD, Chi H, Huang FY, Lee ML, Huang YC, Hwang B, Chiu NC, Hwang KP, Lee PC, Chang LC, Liu YM, Chen YJ, Chen CH, Taiwan Pediatric ID Alliance, Chen YT, Tsai FJ, Wu JY (2012) Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 44:522–525. doi:10.1038/ng.2227 CrossRefPubMed

16.

Li Q, Xie J, He L, Wang Y, Duan Z, Yang H, Wang Q (2015) Identification of ADAM10 and ADAM17 with potential roles in the spermatogenesis of the Chinese mitten crab, Eriocheir sinensis. Gene 562:117–127. doi:10.1016/j.gene.2015.02.060 CrossRefPubMed

17.

Liu C, Xu P, Lamouille S, Xu J, Derynck R (2009) TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Mol Cell 35:26–36. doi:10.1016/j.molcel.2009.06.018 CrossRefPubMedPubMedCentral

18.

Lou J, Xu S, Zou L, Zhong R, Zhang T, Sun Y, Lu X, Liu L, Li C, Wang L, Xiong G, Wang W, Gong F, Wu J (2012) A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis. Mol Biol Rep 39:11137–11144. doi:10.1007/s11033-012-2022-0 CrossRefPubMed

19.

Lue HC, Chen LR, Lin MT, Chang LY, Wang JK, Lee CY, Wu MH (2014) Epidemiological features of Kawasaki disease in Taiwan, 1976-2007: results of five nationwide questionnaire hospital surveys. Pediatr Neonatol 55:92–96. doi:10.1016/j.pedneo.2013.07.010 CrossRefPubMed

20.

Ma XJ, Yu CY, Huang M, Chen SB, Huang MR, Huang GY; Shanghai Kawasaki Research Group (2010) Epidemiologic features of Kawasaki disease in Shanghai from 2003 through 2007. Chin Med J (Engl) 123:2629–2634

21.

Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotani K, Yanagawa H (2015) Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol 25:239–245. doi:10.2188/jea.JE20140089 CrossRefPubMed

22.

Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P (1997) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16:5353–5362CrossRefPubMedPubMedCentral

23.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Pediatrics 114:1708–1733CrossRefPubMed

24.

Niu A, Wen Y, Liu H, Zhan M, Jin B, Li YP (2013) Src mediates the mechanical activation of myogenesis by activating TNFα-converting enzyme. J Cell Sci 126:4349–4357. doi:10.1242/jcs.125328 CrossRefPubMedPubMedCentral

25.

Onouchi Y (2012) Genetics of Kawasaki disease: what we know and don’t know. Circ J 76:1581–1586CrossRefPubMed

26.

Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Nakamura Y, Hata A (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35–42CrossRefPubMedPubMedCentral

27.

Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, Terai M, Honda A, Takeuchi T, Shibuta S, Suenaga T, Suzuki H, Higashi K, Yasukawa K, Suzuki Y, Sasago K, Kemmotsu Y, Takatsuki S, Saji T, Yoshikawa T, Nagai T, Hamamoto K, Kishi F, Ouchi K, Sato Y, Newburger JW, Baker AL, Shulman ST, Rowley AH, Yashiro M, Nakamura Y, Wakui K, Fukushima Y, Fujino A, Tsunoda T, Kawasaki T, Hata A, Nakamura Y, Tanaka T (2010) Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 19:2898–2906. doi:10.1093/hmg/ddq176 CrossRefPubMedPubMedCentral

28.

Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, Honda T, Suzuki H, Suenaga T, Takeuchi T, Yoshikawa N, Suzuki Y, Yasukawa K, Ebata R, Higashi K, Saji T, Kemmotsu Y, Takatsuki S, Ouchi K, Kishi F, Yoshikawa T, Nagai T, Hamamoto K, Sato Y, Honda A, Kobayashi H, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Murata Y, Sasago K, Takahashi A, Kamatani N, Kubo M, Tsunoda T, Hata A, Nakamura Y, Tanaka T, Japan Kawasaki Disease GenomeConsortium, US Kawasaki Disease Genetics Consortium (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44:517–521. doi:10.1038/ng.2220 CrossRefPubMed

29.

Palazuelos J, Crawford HC, Klingener M, Sun B, Karelis J, Raines EW, Aguirre A (2014) TACE/ADAM17 is essential for oligodendrocyte development and CNS myelination. J Neurosci 34:11884–11896. doi:10.1523/JNEUROSCI.1220-14.2014 CrossRefPubMedPubMedCentral

30.

Poon CE, Madawala RJ, Day ML, Murphy CR (2015) EpCAM is decreased but is still present in uterine epithelial cells during early pregnancy in the rat: potential mechanism for maintenance of mucosal integrity during implantation. Cell Tissue Res 359:655–664. doi:10.1007/s00441-014-2017-3 CrossRefPubMed

31.

Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, Frazer JR, Sun S, Baker AL, Newburger JW, Rowley AH, Shulman ST, Burgner D, Breunis WB, Kuijpers TW, Wright VJ, Levin M, Eleftherohorinou H, Coin L, Popper SJ, Relman DA, Fury W, Lin C, Mellis S, Tremoulet AH, Burns JC (2011) Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 4:16–25. doi:10.1161/CIRCGENETICS.110.940858 CrossRefPubMedPubMedCentral

32.

Shimizu C, Kim J, Stepanowsky P, Trinh C, Trinh C, Lau HD, Akers JC, Chen C, Kanegaye JT, Tremoulet A, Ohno-Machado L, Burns JC (2013) Differential expression of miR-145 in children with Kawasaki disease. PLoS One 8, e58159. doi:10.1371/journal.pone.0058159 CrossRefPubMedPubMedCentral

33.

Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC (2013) The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol 44:189–198. doi:10.1016/j.humpath.2012.05.004 CrossRefPubMedPubMedCentral

34.

Singh S, Vignesh P, Burgner D (2015) The epidemiology of Kawasaki disease: a global update. Arch Dis Child 100:1084–1088. doi:10.1136/archdischild-2014-307536 CrossRefPubMed

35.

Villaverde-Hueso A, Alonso V, Morales-Piga A, Hens-Pérez M, Abaitua I, Posada-de-la-Paz M (2014) Childhood vasculitis hospitalizations in Spain, 1997-2011. Georgian Med News 230:65–72PubMed

36.

Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105:e78CrossRefPubMed

37.

Wu W, Misra RS, Russell JQ, Flavell RA, Rincón M, Budd RC (2006) Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3. J Biol Chem 281:10682–10690CrossRefPubMed

38.

Xing Y, Wang H, Liu X, Yu X, Chen R, Wang C, Yu X, Sun L (2014) Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease. Mol Biol Rep 41:6377–6381. doi:10.1007/s11033-014-3517-7 CrossRefPubMed

39.

Yan Y, Ma Y, Liu Y, Hu H, Shen Y, Zhang S, Ma Y, Tao D, Wu Q, Peng Q, Yang Y (2013) Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese. Hum Genet 132:669–680. doi:10.1007/s00439-013-1279-2 CrossRefPubMed

Title: Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway
Authors: Qian Peng
Yan Deng
Xiling Yang
Xiangyou Leng
Yuan Yang
Hanmin Liu
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Pediatrics / Issue 5/2016
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-016-2696-8

At a glance: The STEP trials

Springer Medicine

Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2016

Do internationally adopted children in the Netherlands use more medication than their non-adopted peers?

Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results

CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature—a rare case with a novel mutation

Motivations of children and their parents to participate in drug research: a systematic review

Outcome after prenatal diagnosis of congenital anomalies of the kidney and urinary tract

Sleep in children with attention-deficit/hyperactivity disorder (ADHD) before and after 6-month treatment with methylphenidate: a pilot study